Immune checkpoints such as CTLA-4 (cytotoxic T lymphocyte-associated antigen-4) and PD-1 (programmed cell death protein 1), which regulate the activation of lymphocytes and balance immune responses, can protect tumor cells from the immune response. Here, PDCD1 is linked to neoplasm.